Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients

Podobne zapisy

• Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients
  od: Frank Bidar, i wsp.
  Wydane: (2022-04-01)
• Altered Ex Vivo NLRP3 Inflammasome Activation Is Associated with 28-Day Mortality in Septic Patients
  od: Rémy Coudereau, i wsp.
  Wydane: (2023-12-01)
• Monitoring NLRP3 Inflammasome Activation and Exhaustion in Clinical Samples: A Refined Flow Cytometry Protocol for ASC Speck Formation Measurement Directly in Whole Blood after Ex Vivo Stimulation
  od: Rémy Coudereau, i wsp.
  Wydane: (2022-10-01)
• Monitoring monocyte HLA-DR expression and CD4 + T lymphocyte count in dexamethasone-treated severe COVID-19 patients
  od: Guillaume Monneret, i wsp.
  Wydane: (2024-05-01)
• Identification of a sub-group of critically ill patients with high risk of intensive care unit-acquired infections and poor clinical course using a transcriptomic score
  od: Maxime Bodinier, i wsp.
  Wydane: (2023-04-01)